The Food and Drug Administration (FDA) attempts to avoid making type II errors. A type II error occurs when the FDA approves a drug that is not both safe and effective. Despite the FDA's eorts, bad drugs do on occasion get through to the public. As an example, Fenoterol was found to increase the risk of death for asthma patients. Is there any way for the FDA to completely eliminate the occurrence of type II errors? Explain briefly.